Lexeo Therapeutics LXEO
NASDAQ LXEO
$3.42 +0.00 (+0.15%)
As of: Sep 30, 2026 · 10:01 AM EDT

Lexeo Therapeutics (LXEO) Operating Expenses (2022 - 2026)

Updated

Lexeo Therapeutics' Operating Expenses came in at $28.02 million for Q2 2026, down 8.7% from $30.69 million a year earlier but up 25.5% from the prior quarter.

Analysis

Lexeo Therapeutics (LXEO) Operating Expenses (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Lexeo Therapeutics reported Operating Expenses of $95.12 million, down 22.9% year-over-year; for FY2025, it was $109.26 million, up 3.3% from FY2024.

  • Operating Expenses has increased in each of the last three years, with a three-year compound annual growth rate of 21.3% (FY2022 to FY2025).
  • Going back by year, Operating Expenses was $105.77 million in FY2024 (+54.4%), $68.51 million in FY2023 (+12.0%) and $61.16 million in FY2022.
  • The five-year range for quarterly Operating Expenses is $13.98 million (Q2 2023) to $33.81 million (Q1 2025).
  • Year-over-year, Operating Expenses has declined for four consecutive quarters, with growth averaging 15.5% over the last eight quarters.
  • The fastest year-over-year change in Operating Expenses over five years came in Q4 2024 (growth of 82.9%), and the weakest in Q1 2026 (a decline of 33.9%).
  • Business Quant data shows LXEO's Operating Expenses at $22.33 million (Q1 2026), $23.12 million (Q4 2025) and $21.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Lexeo Therapeutics 246.87 Mn 246.87 Mn - 28.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.02 Mn
Mar 31, 2026 22.33 Mn
Dec 31, 2025 23.12 Mn
Sep 30, 2025 21.65 Mn
Jun 30, 2025 30.69 Mn
Mar 31, 2025 33.81 Mn
Dec 31, 2024 27.38 Mn
Sep 30, 2024 31.54 Mn
Jun 30, 2024 23.55 Mn
Mar 31, 2024 23.29 Mn
Dec 31, 2023 14.97 Mn
Sep 30, 2023 20.27 Mn
Jun 30, 2023 13.98 Mn
Mar 31, 2023 19.29 Mn
Dec 31, 2022 15.20 Mn
Sep 30, 2022 18.01 Mn
API Access

Lexeo Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=LXEO&period=max&api_key=YOUR_API_KEY